THYQUIDITY
These highlights do not include all the information needed to use safely and effectively. (levothyroxine sodium) oral solution Initial U.S. Approval: 2000
Approved
Approval ID
67dbca4d-1aea-48f8-a013-c14d5dc75f50
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 14, 2022
Manufacturers
FDA
VistaPharm, Inc.
DUNS: 116743084
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levothyroxine Sodium
PRODUCT DETAILS
NDC Product Code66689-105
Application NumberNDA214047
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateSeptember 14, 2022
Generic NameLevothyroxine Sodium
INGREDIENTS (6)
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
LEVOTHYROXINE SODIUMActive
Quantity: 100 ug in 5 mL
Code: 9J765S329G
Classification: ACTIR
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLPARABEN SODIUMInactive
Code: CR6K9C2NHK
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT